What it sells
A research lab for one
Business model breakdown
Buyer: who owns the budget?
UnverifiedComplex-case patients or families and their treating clinicians who refer cases (cases begin by emailing a non-identifying brief to the team).
Trigger: what makes them buy now?
UnverifiedA complex or hard-to-treat case (e.g. cancer) where routine diagnostics leave unanswered biological questions and standard-of-care options are exhausted or unclear.
Workflow: what inputs become what output?
Email case brief (reply within 24 hours), scientist reviews fit, scope defined, secure intake (identifying records by designated fax), team collects records/imaging/pathology/molecular data, coordinates added diagnostic testing, integrates a multimodal profile, assesses therapeutic options against evidence, and returns rationale and next questions to the clinical team.
Economics: what it saves and how it charges
UnverifiedPer-case research service delivered by a dedicated PhD scientist team; fee model not published.
Distribution: how it reaches customers
Clinician referral and direct inquiry by email ('Begin a conversation'); no self-serve.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2026 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.